{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:06:56Z","timestamp":1792206416545,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":3420,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 HL72917"],"award-info":[{"award-number":["R01 HL72917"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 HL89746"],"award-info":[{"award-number":["R01 HL89746"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U54 HL112303"],"award-info":[{"award-number":["U54 HL112303"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/jth.12319","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T13:32:56Z","timestamp":1371216776000},"page":"1511-1518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura"],"prefix":"10.1016","volume":"11","author":[{"given":"J.","family":"Muia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Haberichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Dolatshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Westfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Covill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.D.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12319_bb0010","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor\u2010cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic\u2010uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12319_bb0015","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor\u2010cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12319_bb0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12319_bb0025","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12319_bb0030","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12319_bb0035","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1055\/s-0037-1614780","article-title":"Assay of von Willebrand factor (vWF)\u2010cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)","volume":"82","author":"Gerritsen","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12319_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS\u2010VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12319_bb0045","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1538-7836.2008.03099.x","article-title":"Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS\u201013)","volume":"6","author":"Tripodi","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12319_bb0050","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.12319_bb0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1160\/TH10-06-0417","article-title":"Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies","volume":"105","author":"Palla","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12319_bb0060","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1529\/biophysj.108.131532","article-title":"Mechanistic studies on ADAMTS13 catalysis","volume":"95","author":"Di Stasio","year":"2008","journal-title":"Biophys J"},{"key":"10.1111\/jth.12319_bb0065","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1538-7836.2007.02438.x","article-title":"Hyperbilirubinemia interferes with ADAMTS\u201013 activity measurement by FRETS\u2010VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies","volume":"5","author":"Meyer","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12319_bb0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3324\/haematol.2011.051433","article-title":"Evidence for a role of anti\u2010ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura","volume":"97","author":"Froehlich\u2010Zahnd","year":"2012","journal-title":"Haematologica"},{"key":"10.1111\/jth.12319_bb0075","doi-asserted-by":"crossref","first-page":"13406","DOI":"10.1074\/jbc.270.22.13406","article-title":"Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged\u2010to\u2010alanine scanning mutagenesis of the A1 domain of human von Willebrand factor","volume":"270","author":"Matsushita","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12319_bb0080","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1093\/nar\/18.20.6069","article-title":"Ligation\u2010independent cloning of PCR products (LIC\u2010PCR)","volume":"18","author":"Aslanidis","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/jth.12319_bb0085","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1110\/ps.8.8.1668","article-title":"Escherichia coli maltose\u2010binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused","volume":"8","author":"Kapust","year":"1999","journal-title":"Protein Sci"},{"key":"10.1111\/jth.12319_bb0090","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1538-7836.2006.01833.x","article-title":"ADAMTS\u201013 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences","volume":"4","author":"Feys","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12319_bb0095","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/j.1538-7836.2009.03620.x","article-title":"Multi\u2010step binding of ADAMTS\u201013 to von Willebrand factor","volume":"7","author":"Feys","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12319_bb0100","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1074\/jbc.M504540200","article-title":"Zinc and calcium ions cooperatively modulate ADAMTS13 activity","volume":"281","author":"Anderson","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12319_bb0105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2004-06-2096","article-title":"Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin","volume":"105","author":"Studt","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.12319_bb0110","unstructured":"NCCLS. Protocols for determination of limits of detection and limits of quantitation; approved guideline. NCCLS document EP17\u2010A. 940 West Valley Road, Suite 1400, Wayne, PA, USA: NCCLS, 2004; 1\u201339."},{"key":"10.1111\/jth.12319_bb0115","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2009-01-195461","article-title":"Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site","volume":"114","author":"Raife","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12319_bb0120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1538-7836.2006.01904.x","article-title":"Measurement of ADAMTS\u201013 activity in plasma by the FRETS\u2010VWF73 assay: comparison with other assay methods","volume":"4","author":"Kremer Hovinga","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12319_bb0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2012-01-403113","article-title":"Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura","volume":"120","author":"Lotta","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12319_bb0130","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-11-4035","article-title":"Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.12319_bb0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2141.2005.05837.x","article-title":"Prognostic value of inhibitory anti\u2010ADAMTS13 antibodies in adult\u2010acquired thrombotic thrombocytopenic purpura","volume":"132","author":"Coppo","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12319_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3324\/haematol.11739","article-title":"ADAMTS13 and anti\u2010ADAMTS13 antibodies are markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission","volume":"93","author":"Peyvandi","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/jth.12319_bb0145","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1538-7836.2012.04808.x","article-title":"ADAMTS\u201013 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura","volume":"10","author":"Bettoni","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12319_bb0150","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3324\/haematol.2011.042945","article-title":"ADAMTS13 activity and antigen during therapy and follow\u2010up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcome","volume":"96","author":"Yang","year":"2011","journal-title":"Haematologica"},{"key":"10.1111\/jth.12319_bb0155","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood-2006-02-006064","article-title":"Prognostic value of anti\u2010ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity","volume":"109","author":"Ferrari","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.12319_bb0160","first-page":"387","article-title":"Inhibitors of von Willebrand factor\u2010cleaving protease in thrombotic thrombocytopenic purpura","volume":"47","author":"Tsai","year":"2001","journal-title":"Clin Lab"},{"key":"10.1111\/jth.12319_bb0165","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood-2011-03-341131","article-title":"A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura","volume":"118","author":"Scully","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.12319_bb0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/CCM.0b013e31822e9d66","article-title":"Efficacy and safety of first\u2010line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French thrombotic microangiopathies reference center","volume":"40","author":"Froissart","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1111\/jth.12319_bb0175","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-0609.2012.01767.x","article-title":"Long\u2010term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements","volume":"88","author":"Knovich","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.12319_bb0180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jth.12114","article-title":"Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse","volume":"11","author":"Westwood","year":"2013","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12319","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12319","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622136494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622136494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12319\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:04:48Z","timestamp":1761534288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622136494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1538783622136494"],"URL":"https:\/\/doi.org\/10.1111\/jth.12319","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}